Introduction 29
The Mediterranean diet (MedDiet) is a plant-based diet, consisting mostly of fresh fruits, 30 vegetables, grains, nuts and legumes, abundant extra virgin olive oil and moderate fish, 31 poultry and dairy foods (1, 2) . Clinical trials have demonstrated reduced risk of incident 32 cardiovascular disease (CVD) in high risk individuals, reoccurrence of CVD in secondary 33 patients, and overall mortality (3) (4) (5) , whilst epidemiological, longitudinal and prospective 34 studies show reduced risk of incident CVD, total and cause-specific mortality, diabetes, 35 metabolic syndrome and Alzheimer's disease (6) (7) (8) (9) (10) . Furthermore, the effects of the diet on 36 intermediate markers of CVD risk have been investigated, suggesting possible biological 37 mechanisms of effect. The MedDiet has been linked to improved blood pressure and 38 endothelial function, triglycerides and other lipids, glucose and insulin control, reduced 39 oxidative stress and inflammatory markers including high sensitivity C-reactive protein (hs-40 CRP), interleukin-6 and other pro-inflammatory cytokines (9, (11) (12) (13) (14) (15) (16) . 41 The range of health benefits has mostly been established through long term prospective 42 observational trials and short term dietary intervention trials (17) (18) (19) (20) (21) . Furthermore, 43 populations studied tend to be Mediterranean, at high risk of CVD or CVD patients. 44 Randomised trials involving individuals without risk factors beyond the Mediterranean region 45 are still scarce. Extension of MedDiet principles beyond Mediterranean countries may 46 contribute to reducing the high burden of chronic disease in many Western countries. 47 Generally the MedDiet is considered palatable and transposable, making it a potential dietary 48 strategy for improving health in Western populations (22) . 49 To better understand how this dietary pattern might improve CVD risk factors in non-50
Mediterranean countries we aimed to determine whether adherence would result in changes 51 to plasma lipids, glucose and insulin, hs-CRP and F 2 -Isoprostanes (F 2 -IsoP) in an Australianpopulation. Older adults were targeted due to their increasing risk of developing age-related 53 chronic disease. We did not specifically recruit an at risk population to include healthy adults. 54 We hypothesised that increased adherence to a MedDiet would improve markers of 55 cardiovascular health. 56 Additionally, participants attended the clinic bi-weekly to meet with a dietitian, to ensure 77 high adherence to the dietary protocol. The study was approved by the human research ethics 78 committee of the University of South Australia (#31163) and was registered with the 79 Australian and New Zealand Clinical Trial Registry, (ACTRN12613000602729). 80
Diets and bi-weekly appointments 81
The intervention diet was based on a traditional MedDiet, with small adaptations to the 82 Australian food supply. For example, wholegrain breakfast cereals, canned fish and legumes, 83 some tropical fruits and Asian vegetables were allowed, although traditional foods were 84 encouraged over these non-traditional foods. Detailed information on the formulation and 85 final intervention diet is described by Davis et al. (23) . It comprised extra-virgin olive oil, 86 vegetables, fruits, nuts, whole grains, legumes and fish as core foods. The diet was moderate 87 in red wine and dairy foods (primarily cheese and yogurt) and contained small amounts of red 88 meat, small goods and discretionary foods. Supplemental table 1 shows the number of 89 servings recommended for these food groups. At baseline, participants attended the clinic and 90 received their dietary allocation. During a 45-min to 1 hour consult with a study dietitian, the 91 principles of the allocated diet were described in detail. For those in the MedDiet group, a 92 written guide including a MedDiet pyramid and other background information, serving sizes, 93 recommended number of servings of key foods, guidelines for recipe modification and eating 94 out as well as a Mediterranean recipe book were provided. Daily checklists to record intake 95 of servings were also provided. To aid adherence, 100% of the recommended extra virgin 96 olive oil, nuts (50% walnuts, 25% almonds and hazelnuts), Greek yogurt and canned legumes 97 was provided to the participants. Additionally canned tuna was given to provide 30% of the 98 fish requirements. The exact amounts of these foods provided is reported elsewhere (23 analyser was used. Analysis of insulin was performed using a Siemens Centaur XP and 123 analysis of hs-CRP was performed using a Beckman Coulter 2700. Serum carotenoids wereassessed using high performance liquid chromatography by the technique described by Barua 125 et al. (26) , and erythrocyte fatty acids were measured by direct transesterification described by 126
Tu et al. (27) . All analyses were performed according to the manufacturer's instructions (28-127 33) . Blood for the analysis of F 2 -IsoPs was collected on ethyldiaminetetraacetic acid, and 128 analysed using gas chromatography mass spectrometry according to the method of Barden 
)). 137
Statistics 138
Normally distributed continuous variables are described using mean±SD and non-normally 139 distributed variables using median (IQR). Between group differences at baseline were tested 140 using independent samples t tests or Mann-Whitney U tests for non-normally distributed data. 141 Table 1 , and are compared to 160 recommendations (36-39). Baseline dietary characteristics and change to 4 months are shown 161 in Table 2 . There was no statistical difference in outcome measures between groups at 162 baseline for clinical or dietary characteristics, with the exception of iron (lower in the control 163 group). Stratification resulted in equally balanced groups for gender, age and BMI. Men and 164 women had a mean waist circumference of 96.8±10.6 cm and 85.3±11.8 cm respectively, 165 placing them at increased risk of CVD (38) . Triglycerides and HDL were within 166 recommendations while total cholesterol and LDL were elevated amongst both groups (36). 167 Shown in table 2, there were some significant changes in dietary intake within both groups; 168 however changes were generally smaller in the control group. Main outcome data are 169 summarised in Table 3 . Compared with HabDiet, MedDiet resulted in lower triglycerides andgroups at any time point. There was no change in 24-hour urinary metabolite excretion within 173 groups between baseline, 3 and 6 months. Within the control group, there were no significant 174 changes in serum carotenoids or erythrocyte fatty acids. Within the MedDiet group, there was 175 a significant increase in serum α-carotene between baseline and 6 months ( In the present study, compared with a habitual Australian diet, following a MedDiet for 6 183 months resulted in a significant reduction in triglycerides and F 2 -IsoP whilst weight remained 184 stable. The diet had no effect on total cholesterol, LDL or HDL, glucose, insulin or hs-CRP. clinically relevant protection from CVD is yet unknown, however this study suggests our 231 findings may be clinically relevant (48) . 232
Our null findings for total cholesterol, LDL, HDL and body composition may due to several 233 reasons. Our sample may have been healthier than in previous studies, where an at-risk 234 population is targeted. In the Prevención con Dieta Mediterránea study, approximately 65% 235 of recruits from the first 6 months had dyslipidaemia, compared to 44% in this study (16) . 236
Thirty three per cent on the MedDiet and 26% on the HabDiet were taking cholesterol 237 lowering medications, which may also have prevented a significant reduction. There was no 238 change in insulin or glucose levels. The MedDiet has been linked to reduced onset of diabetes 239 in an at-risk population; however we excluded those with Type 2 Diabetes, or elevated 240 glucose at baseline (8) . We deliberately aimed to prevent change in body mass or physical 241 activity, thus could expect little change in body composition. The role of BMI in disease risk 242 is well understood. Ezzati et al. (55) showed evidence that globally, high BMI is the third 243 largest contributor to death and burden of disease in high-income regions. Previously there 244 have been concerns that the MedDiet may promote obesity due to its high fat content, and 245 energy dense components (for example, olive oil, nuts and oily fish). In fact, studies haveshown the MedDiet is associated reduced risk of overweight and obesity (56) (57) (58) . Evidence 247 from the Seguimiento University of Navarra study (SUN cohort), the European Investigation 248 into Cancer and Nutrition study and ATTICA studies all suggest an inverse association 249 between BMI and increasing adherence (57, 59) . Evidence from long-term randomised trials 250 is lacking. Interventions where a MedDiet has resulted in weight loss tend to have restricted 251 energy intakes (19, 60). In our study energy intake was kept constant to prevent weight 252 change, thus our results suggest the diet is unlikely to result in weight loss without energy 253
restriction. 254
The results are limited by several factors. We did not exclude persons taking medications, 255 which may have altered or masked changes in the lipid profile, particularly LDL. This also 256 may explain why cholesterol levels were unchanged, while triglyceride levels decreased; 257 medications tend not to affect triglycerides (43) . The study was not blinded, with both 258 participant groups and all investigators aware of the nature of the intervention. This may have 259 led to the control group altering their diets in line with MedDiet principles, despite efforts to 260 discourage this practice. This change if it occurred was not observed through the WFRs, 261 which we acknowledge are self-reported and therefore subject to biases. We did not closely 262 monitor physical activity, although participants were told to maintain physical activity and 263 asked to report major changes fortnightly, of which none were reported. The study strengths 264 include the randomised controlled design ensuring theoretically balanced groups at baseline, 265 highly controlled conditions for measurements, well-adhered to data collection protocols and 266 good adherence to the dietary protocol within the two groups. 267
Conclusion 268
In this randomised, parallel controlled intervention trial amongst older Australians, adhering 269 to the MedDiet resulted in reduced triglycerides compared to the habitual Australian diet after Total erythrocyte saturated fat (%) -0.5 ± 0.9 <0.001 0.1 ± 1. 
